Analystreport

Portola Pharmaceuticals (NASDAQ: PTLA) had its price target raised by analysts at Citigroup to $64.00. They now have a "buy" rating on the stock.

PORTOLA PHARMACEUTICALS  (PTLA) 
Last portola pharmaceuticals earnings: 2/26 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.portola.com